FDA Approves Gene Therapy Lenmeldy for Metachromatic Leukodystrophy (MLD)
source: pixabay.com

FDA Approves Gene Therapy Lenmeldy for Metachromatic Leukodystrophy (MLD)

A majority of available treatment options for metachromatic leukodystrophy (MLD) rely on relieving symptoms. However, the recent approval of Lenmeldy (atidarsagene autotemcel) is the first ever FDA-approved gene therapy option…

Continue Reading FDA Approves Gene Therapy Lenmeldy for Metachromatic Leukodystrophy (MLD)
ALD and MLD to be Screened in Newborns in UK Generation Study
source: shutterstock.com

ALD and MLD to be Screened in Newborns in UK Generation Study

Patient Worthy partner Alex TLC has announced that, in a large-scale newborn screening study supported by the UK's NHS and Genomics England, adrenoleukodystrophy (ALD) and metachromatic leukodystrophy (MLD) will be…

Continue Reading ALD and MLD to be Screened in Newborns in UK Generation Study
Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
source: pixabay.com

Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology

As reported in Biospace, the National Organization for Rare Disorders (NORD) has just opened registration for patients to take part in a natural history study on metachromatic leukodystrophy (MLD), a…

Continue Reading Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
source: pixabay.com

OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)

  The development of treatments and medicines for diseases can take a long time. These treatments come from many hours of research, studies, trials, and waiting for approval from the…

Continue Reading OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)

Preclinical Findings for Phenylketonuria and Metachromatic Leukodystrophy Gene Therapies Look Promising

According to a story from BioSpace, the genetic medicines company Homology Medicines, Inc., has recently released preclinical data supporting the development of two experimental gene therapies. One, called HMI-202, is…

Continue Reading Preclinical Findings for Phenylketonuria and Metachromatic Leukodystrophy Gene Therapies Look Promising